All Cases
Enterprise
Contact us
Connect Portfolio
Sign In
Homepage
Enterprise
Contact us
All Cases
Connect Portfolio
Okta Inc
Attorney Investigation
For Holders On:
03 March 2021
Bloomberg reported that "Okta Inc., a maker of identity-verification software, agreed to buy smaller rival Auth0 for about $6.5 billion i...
Mismanagement
Malpractice
Negligence
Omissions
Directors
Management
Collecting participants...
Join Claim
Okta Inc
Attorney Investigation
For Holders On:
31 August 2022
On August 31, 2022, Okta released Q2 2022 earnings report and disclosed that it was having challenges integrating Auth0, the customer ide...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Negligence
Omissions
Directors
Management
Collecting participants...
Join Claim
PVH Corp
Attorney Investigation
For Holders On:
30 August 2022
On August 30, PVH Corp. released Q2 2022 financials and surprised the market by cutting full-year projections. At the same time, the Com...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Negligence
Omissions
Directors
Management
Collecting participants...
Join Claim
Stitch Fix
Attorney Investigation
For Holders On:
08 March 2022
On March 8, 2022, Stitch Fix provided a weak outlook for its Q3 2022 and cut its revenue guidance for the full year. Also, Stitch Fix ann...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Omissions
Directors
Management
Collecting participants...
Join Claim
Coupang LLC
Attorney Investigation
For Holders On:
13 July 2022
On July 13, 2022, The Korea Times published an article reporting that Coupang was under investigation for falsely advertising the members...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Directors
Management
Service Provider
Collecting participants...
Join Claim
Coupang LLC
Attorney Investigation
For Holders On:
11 March 2021
There are grounds to suspect that the Company disclosed information in bad faith as part of the initial offering in March 2021, including...
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Directors
Management
Investment Bank
Service Provider
Collecting participants...
Join Claim
Azure Power Global Ltd
Attorney Investigation
For Holders On:
29 August 2022
On August 29, 2022, the Company disclosed among other things that " it received a whistleblower complaint in May 2022 alleging potential ...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Negligence
Omissions
Directors
Management
Service Provider
Collecting participants...
Join Claim
U.S. Bancorp
Attorney Investigation
For Holders On:
28 July 2022
On July 28, 2022, Consumer Financial Protection Bureau (CFPB) Fines U.S. Bank $37.5 Million for Illegally Exploiting Personal Data to Ope...
Mismanagement
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Directors
Management
Collecting participants...
Join Claim
Twitter Inc
Attorney Investigation
For Holders On:
29 August 2022
On August 29, 2022, Reuters reported that "Elon Musk has sent an additional letter of deal termination to Twitter Inc to include a recent...
Price manipulation
Malpractice
Negligence
Shareholder
Influencer
Collecting participants...
Join Claim
Toronto Dominion Bank
Attorney Investigation
For Holders On:
15 June 2022
On June 15, 2022, CNBC published an article “Sen. Warren asks bank regulator to reject TD’s $13.4 billion acquisition after customer-abu...
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Omissions
Directors
Management
Influencer
Collecting participants...
Join Claim
Molecular Partners AG ADR
Attorney Investigation
For Holders On:
16 November 2021
On November 16, 2021, the company disclosed that "a planned futility analysis of ensovibep in [an] ongoing [Phase 3] clinical study . . ....
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Breach of Fiduciary duty
Omissions
Directors
Management
Collecting participants...
Join Claim
World Wrestling Entertainment Inc
Attorney Investigation
For Holders On:
25 July 2022
On July 25, 2022, WWE filed the SEC report which announced that “the Company has made a preliminary determination that certain payments t...
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Directors
Management
Service Provider
Collecting participants...
Join Claim
World Wrestling Entertainment Inc
Attorney Investigation
For Holders On:
18 June 2022
In mid-2022, WWE faced a scandal over accusations of sexual misconduct and undisclosed payments vs. CEO V. McMahon, leading to his resign...
Financial Misrepresentation
Failure to Disclose
Malpractice
Breach of Fiduciary duty
Omissions
Directors
Management
Collecting participants...
Join Claim
Dingdong ADR
Attorney Investigation
For Holders On:
17 March 2022
On March 17, 2022, a Beijing News reported that Chinese regulators launched a probe into Dingdong for food safety violations uncovered by...
Misleading Statements
Failure to Disclose
Malpractice
Negligence
Omissions
Directors
Management
Service Provider
Collecting participants...
Join Claim
Dingdong ADR
Attorney Investigation
For Holders On:
28 June 2021
On March 17, 2022, a Beijing News reported that Chinese regulators launched a probe into Dingdong for food safety violations uncovered by...
Misleading Statements
Malpractice
Negligence
Omissions
Directors
Management
Collecting participants...
Join Claim
Nio Inc Class A ADR
Attorney Investigation
For Holders On:
11 July 2022
On July 11, 2022, NIO announced that in response to the allegations made in a report issued by the short-seller firm Grizzly Research LLC...
Misleading Statements
Financial Misrepresentation
Fraud
Failure to Disclose
Malpractice
Negligence
Breach of Fiduciary duty
Omissions
Directors
Management
Service Provider
Collecting participants...
Join Claim
Humanigen Inc
Attorney Investigation
For Holders On:
13 July 2022
On July 13, 2022, Humanigen disclosed that lenzilumab had failed to show statistical significance on the primary endpoint of the ACTIV-5/...
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Directors
Management
Collecting participants...
Join Claim
Humanigen Inc
Attorney Investigation
For Holders On:
09 September 2021
On September 9, 2021, Humanigen issued a press release announcing that the FDA had rejected the lenzilumab EUA, advising investors that, ...
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Directors
Management
Collecting participants...
Join Claim
More cases